News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
588,834 Results
Type
Article (34674)
Company Profile (185)
Press Release (553975)
Section
Business (174641)
Career Advice (1819)
Deals (29635)
Drug Delivery (74)
Drug Development (64647)
Employer Resources (149)
FDA (13826)
Job Trends (12776)
News (286755)
Policy (24427)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (6)
2024 BioForest Standard (1)
2024 BioMidwest Digital (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (6)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (2)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (7)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
2026 Genetown Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2382)
Accelerated approval (2)
Adcomms (16)
Allergies (73)
Alliances (45135)
ALS (69)
Alzheimer's disease (1101)
Antibody-drug conjugate (ADC) (104)
Approvals (13846)
Artificial intelligence (258)
Autoimmune disease (15)
Automation (14)
Bankruptcy (242)
Best Places to Work (10494)
BIOSECURE Act (14)
Biosimilars (79)
Biotechnology (134)
Bladder cancer (59)
Brain cancer (24)
Breast cancer (223)
Cancer (1826)
Cardiovascular disease (148)
Career advice (1535)
Career pathing (25)
CAR-T (132)
Cell therapy (376)
Cervical cancer (19)
Clinical research (52082)
Collaboration (761)
Compensation (271)
Complete response letters (12)
COVID-19 (2303)
CRISPR (40)
C-suite (202)
Cystic fibrosis (81)
Data (1842)
Decentralized trials (1)
Denatured (24)
Depression (38)
Diabetes (209)
Diagnostics (6214)
Digital health (17)
Diversity (6)
Diversity, equity & inclusion (37)
Drug discovery (109)
Drug pricing (76)
Drug shortages (17)
Duchenne muscular dystrophy (71)
Earnings (70217)
Editorial (25)
Employer branding (20)
Employer resources (129)
Events (90192)
Executive appointments (586)
FDA (14824)
Featured Employer (40)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (5)
Funding (626)
Gene editing (102)
Generative AI (24)
Gene therapy (262)
GLP-1 (582)
Government (3249)
Grass and pollen (5)
Guidances (42)
Healthcare (16856)
Huntington's disease (15)
IgA nephropathy (21)
Immunology and inflammation (79)
Indications (24)
Infectious disease (2425)
Inflammatory bowel disease (122)
Inflation Reduction Act (8)
Influenza (45)
Intellectual property (78)
Interviews (303)
IPO (13621)
IRA (27)
Job creations (2709)
Job search strategy (1311)
Kidney cancer (8)
Labor market (27)
Layoffs (313)
Leadership (15)
Legal (5452)
Liver cancer (61)
Lung cancer (263)
Lymphoma (116)
Machine learning (4)
Management (48)
Manufacturing (243)
MASH (57)
Medical device (13116)
Medtech (13121)
Mergers & acquisitions (16462)
Metabolic disorders (551)
Multiple sclerosis (60)
NASH (18)
Neurodegenerative disease (56)
Neuropsychiatric disorders (17)
Neuroscience (1514)
NextGen: Class of 2025 (5879)
Non-profit (3614)
Northern California (2116)
Now hiring (10)
Obesity (284)
Opinion (205)
Ovarian cancer (66)
Pain (68)
Pancreatic cancer (70)
Parkinson's disease (116)
Partnered (19)
Patents (170)
Patient recruitment (78)
Peanut (43)
People (49392)
Pharmaceutical (40)
Pharmacy benefit managers (16)
Phase I (16704)
Phase II (22899)
Phase III (17248)
Pipeline (992)
Podcasts (64)
Policy (76)
Postmarket research (1827)
Preclinical (7076)
Press Release (72)
Prostate cancer (83)
Psychedelics (22)
Radiopharmaceuticals (246)
Rare diseases (317)
Real estate (5157)
Recruiting (61)
Regulatory (17300)
Reports (34)
Research institute (2134)
Resumes & cover letters (293)
Rett syndrome (2)
RNA editing (3)
RSV (41)
Schizophrenia (50)
Series A (110)
Series B (72)
Service/supplier (10)
Sickle cell disease (50)
Southern California (1800)
Special edition (13)
Spinal muscular atrophy (97)
Sponsored (27)
Startups (3216)
State (2)
Stomach cancer (5)
Supply chain (51)
The Weekly (39)
United States (18544)
Vaccines (623)
Venture capitalists (28)
Webinars (13)
Weight loss (189)
Women's health (24)
Worklife (13)
Date
Today (125)
Last 7 days (638)
Last 30 days (2485)
Last 365 days (29795)
2025 (7209)
2024 (31349)
2023 (35899)
2022 (46538)
2021 (50175)
2020 (48427)
2019 (42013)
2018 (31615)
2017 (29295)
2016 (28062)
2015 (33001)
2014 (25069)
2013 (20524)
2012 (22215)
2011 (23002)
2010 (21070)
Location
Africa (647)
Alabama (48)
Alaska (7)
Arizona (162)
Arkansas (13)
Asia (35215)
Australia (5974)
California (4771)
Canada (1628)
China (426)
Colorado (232)
Connecticut (219)
Delaware (110)
Europe (78510)
Florida (715)
Georgia (181)
Idaho (53)
Illinois (447)
India (21)
Indiana (253)
Iowa (7)
Japan (138)
Kansas (97)
Kentucky (24)
Louisiana (7)
Maine (61)
Maryland (672)
Massachusetts (3566)
Michigan (214)
Minnesota (357)
Mississippi (2)
Missouri (79)
Montana (29)
Nebraska (23)
Nevada (46)
New Hampshire (68)
New Jersey (1412)
New Mexico (27)
New York (1415)
North Carolina (873)
North Dakota (8)
Northern California (2116)
Ohio (175)
Oklahoma (14)
Oregon (32)
Pennsylvania (1047)
Puerto Rico (9)
Rhode Island (25)
South America (971)
South Carolina (19)
South Dakota (1)
Southern California (1800)
Tennessee (87)
Texas (727)
Utah (147)
Virginia (110)
Washington D.C. (39)
Washington State (443)
West Virginia (3)
Wisconsin (49)
588,834 Results for "hitachi high technologies corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Roche and Hitachi High-Tech extend their 46-year partnership, paving the way for further breakthroughs in diagnostic testing
Roche announced that Hitachi High-Tech and Roche have extended their partnership, committing to at least 10 years of additional collaboration.
May 27, 2024
·
5 min read
Press Releases
Hitachi High-Tech Acquires Majority Interest in Nabsys
August 2, 2024
·
4 min read
Press Releases
Bioz Announces a New Partnership With Hitachi High-Tech Enabling Real-Time Access to Scientific Citation Data
August 20, 2024
·
2 min read
RayStation Used for First-Ever Radiotherapy Treatment with Hitachi’s OXRAY system
RaySearch Laboratories AB (publ) is pleased to announce a milestone in radiotherapy technology where RaySearch’s RayStation®* was used for the world’s first clinical treatment using OXRAY, a new treatment machine from Hitachi.
June 18, 2024
·
3 min read
glp-1
Novo Nordisk Links High-Dose Wegovy to Increased Weight Loss in Phase III Trial
The data suggest the high dose nearly closes the efficacy gap with Zepbound.
January 17, 2025
·
3 min read
·
Nick Paul Taylor
Press Releases
Newly Published Data Supports Effective Delivery of DNA-Based Vaccines Using Vaxxas’ High-Density Microarray Patch (HD-MAP) Delivery Technology
March 5, 2025
·
8 min read
Business
Hitachi High-Tech and Invivoscribe partner to advance molecular diagnostics and precision medicine
Hitachi High-Tech Corporation (“Hitachi High-Tech”) has entered into a strategic partnership (the Partnership) with Invivoscribe, Inc. (“Invivoscribe”), a global provider of blood cancer testing kits and services, by undertaking a minority investment-based, third-party allotment of shares.
May 9, 2022
·
4 min read
GLP-1
Novo’s CagriSema Blunder Underscores Sky-High Investor Expectations for Weight Loss Drugs
Novo Nordisk executives set a high bar for itself when it projected CagriSema could achieve 25% weight loss. When the GLP-1 combo didn’t hit that mark, investors reeled.
December 20, 2024
·
3 min read
·
Annalee Armstrong
Press Releases
HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology
December 16, 2024
·
5 min read
Depression
Neurocrine Gains ‘High-Risk/High-Reward’ Depression Asset From Takeda
Little information has emerged about osavampator, a potentially first-in-class drug, since its promising Phase II performance last spring.
January 28, 2025
·
2 min read
·
Tristan Manalac
1 of 58,884
Next
